vitamin k (phytonadione)
TRANSCRIPT
Clinical Medications WorksheetsGeneric Namephytonadione
Trade NameVitamin K
Classificationfat-soluble vitamins, Antifibrinolytic Agents
Dose10mg
RouteSQ
Time/frequencydaily
Peak3-6 hr
Onset1-2 hr
Duration12-14 hr
Normal dosage range10 mg daily
Why is your patient getting this medicationHypoprothrombinemia due to Vitamin K Deficiency
For IV meds, compatibility with IV drips and/or solutionsN/A
Mechanism of action and indications(Why med ordered)Required for hepatic synthesis of blood coagulation factors II (prothrombin), VII, IX, and X
Nursing Implications (what to focus on) Contraindications/warnings/interactionsHypersensitivity, Hypersensitivity or intolerance to benzyl alcohol (injection only), use cautiously in impaired liver function
Common side effectsNo known common side effects for this drug
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically)No known interactions for this patient
Lab value alterations caused by medicineProthrombin time (PT) should be monitored prior to and throughout vitamin K therapy to determine response to and need for further therapyBe sure to teach the patient the following about this medicationInstruct patient to take this medication as ordered. If a dose is missed, take as soon as remembered unless almost time for next dose. Notify health care professional of missed doses. Cooking does not destroy substantial amounts of vitamin K. Patient should not drastically alter diet while taking vitamin K. Caution patient to avoid IM injections and activities leading to injury. Use a soft toothbrush, do not floss, and shave with an electric razor until coagulation defect is corrected. Advise patient to report any symptoms of unusual bleeding or bruising (bleeding gums; nosebleed; black, tarry stools; hematuria). Patients receiving vitamin K therapy should be cautioned not to take OTC medications without advice of health care professional. Advise patient to inform health care professional of medication regimen prior to treatment or surgery. Advise patient to carry identification at all times describing disease process. Emphasize the importance of frequent lab tests to monitor coagulation factors.
Nursing Process- Assessment(Pre-administration assessment)Monitor for frank and occult bleeding (guaiac stools, Hematest urine, and emesis). Monitor pulse and blood pressure frequently; notify physician immediately if symptoms of internal bleeding or hypovolemic shock develop. Inform all personnel of patient's bleeding tendency to prevent further trauma. Apply pressure to all venipuncture sites for at least 5 min; avoid unnecessary IM injections
AssessmentWhy would you hold or not give this med?Toxicity (hemolytic anemia, brain damage), clot formation (e.g., DVT, pulmonary emboli)
EvaluationCheck after givingPrevention of spontaneous bleeding or cessation of bleeding in patients with hypoprothrombinemia secondary to impaired intestinal absorption or oral anticoagulant, salicylate, or anti-infective therapy.